Literature DB >> 8580660

Pituitary down-regulation in IVF cycles: is it necessary to use strict criteria?

C Calhaz-Jorge1, F Leal, I Cordeiro, H Proença, M Barata, A M Pereira-Coelho.   

Abstract

PURPOSE: In a retrospective study we have reviewed the data of 570 consecutive IVF cycles in which a GnRH agonist (GnRHa) was started in the early follicular phase (long protocol). Cycles were divided in groups according to estradiol levels before HMG administration: A, < 20 pg/ml; B, 20 to 50 pg/ml; C, 51 to 100 pg/ml. Our objective was to determine if the degree of pituitary suppression had any effect on the ovarian response to stimulation by exogenous gonadotropins, and/or on the IVF outcome.
RESULTS: There were no significant differences in cycle cancellation rates, no. of days of stimulation and ampoules of HMG, serum estradiol after HMG, no. of oocytes retrieved and fertilization rates between groups. Pregnancy rates (19.4%, 21% and 31.8%/cycle, and 24.1%, 27.5% and 37.8% / embryo transfer, respectively) and live-birth rates (16.2%, 16.1% and 25.0%/cycle, 20.1%, 21.2% and 29.7%/embryo transfer, respectively) were also not significantly different.
CONCLUSIONS: The degree of pituitary suppression had no effects on either the ovarian response to gonadotropins (including HMG requirements) or the overall IVF results.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580660     DOI: 10.1007/bf02212585

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  23 in total

1.  The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials.

Authors:  E G Hughes; D M Fedorkow; S Daya; M A Sagle; P Van de Koppel; J A Collins
Journal:  Fertil Steril       Date:  1992-11       Impact factor: 7.329

2.  Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression.

Authors:  R Fleming; J R Coutts
Journal:  Fertil Steril       Date:  1986-02       Impact factor: 7.329

3.  Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins.

Authors:  R N Porter; W Smith; I L Craft; N A Abdulwahid; H S Jacobs
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

4.  An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

Authors:  P Serafini; B Stone; J Kerin; J Batzofin; P Quinn; R P Marrs
Journal:  Fertil Steril       Date:  1988-01       Impact factor: 7.329

5.  Alternatives to IVF: the outcome of 1071 first GIFT procedures.

Authors:  I Craft; P Brinsden
Journal:  Hum Reprod       Date:  1989-11       Impact factor: 6.918

6.  Programming in vitro fertilization for a 5- or 3-day week.

Authors:  E S Dimitry; S A Bates; T Oskarsson; R Margara; R M Winston
Journal:  Fertil Steril       Date:  1991-05       Impact factor: 7.329

7.  Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin.

Authors:  S L Tan; N Maconochie; P Doyle; S Campbell; A Balen; J Bekir; P Brinsden; R G Edwards; H S Jacobs
Journal:  Am J Obstet Gynecol       Date:  1994-08       Impact factor: 8.661

8.  Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization.

Authors:  M G Hull; R J Armatage; A McDermott
Journal:  Fertil Steril       Date:  1994-11       Impact factor: 7.329

9.  Ultrasonic control without hormone determination for ovulation induction in in-vitro fertilization/embryo transfer with gonadotrophin-releasing hormone analogue and human menopausal gonadotrophin.

Authors:  A Golan; A Herman; Y Soffer; I Bukovsky; R Ron-El
Journal:  Hum Reprod       Date:  1994-09       Impact factor: 6.918

10.  Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins.

Authors:  L Wildt; K Diedrich; H van der Ven; S al Hasani; H Hübner; R Klasen
Journal:  Hum Reprod       Date:  1986-01       Impact factor: 6.918

View more
  1 in total

1.  The Impact of Down-Regulation on Obstetrics and Perinatal Outcomes in Singleton Pregnancies After In Vitro Fertilization.

Authors:  Lei Jin; Jihui Ai; Yu Zheng; Biao Chen; Lan Wang; Xiyuan Dong
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-10       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.